Media Summary: What Matters: Dr. William J. Gradishar, associate editor of The Oncology Report, discusses the conflicting results from multiple ... Dr. Rowan Chlebowski of Harbor-UCLA's medical center discusses two studies that suggest bisphophonates In this video, we take a deep dive into the potential
Overview

Do Bisphosphonates Reduce Cancer Risks - Detailed Analysis

What Matters: Dr. William J. Gradishar, associate editor of The Oncology Report, discusses the conflicting results from multiple ... Dr. Rowan Chlebowski of Harbor-UCLA's medical center discusses two studies that suggest bisphophonates In this video, we take a deep dive into the potential Dr. Clay Couvillon explains how a class of drugs known as Julie R. Gralow, MD, director, Breast Medical Oncology, Seattle Julie R. Gralow, MD, Director, Breast Medical Oncology, Seattle

Mary-Ann Dalzell, an oncology clinical specialist, discusses the role of Debu Tripathy, MD, CURE's editor-in-chief, explains recent results from various clinical trials studying the effects of ... Debu Tripathy, MD; Co-leader Women's Breast Wolfgang Janni, MD, PhD, of the University of Ulm, Ulm, Germany, talks about his side of the debate of whether denosumab or ... Caralyn Duignan, 53, from Crewe, was diagnosed with breast Please click on this link to create a free Prostate

Dr. Hope S. Rugo, associate editor of The Oncology Report, discusses the use of

Gallery

Photo Gallery

Related

Related Patients